Long-Term Central Venous Catheters

One Patient, One Catheter

A Central Venous Catheter that puts your patient first.

Selecting the right vascular access device has become more important — particularly for patients with renal issues, chronic patients with poor peripheral access or those with a history of, or risk for, venous thrombosis. The Arrowg+ard Blue Advance JACC is a state-of-the-art alternative to traditional acute CVCs and peripheral central venous access. This new CVC, for acute or long-term use, combines antimicrobial and antithrombogenic protection with smaller french sizes to meet the unique challenges posed by some patients today.

View Our Product Catalog


Types of Patients Who Can Benefit from the Arrowg+ard Blue Advance JACC

References:

  1. Collins JL, Lutz RJ. In vitro Study of Simultaneous Infusion of Incompatible Drugs in Multilumen Catheters. Heart & Lung. 1991; 20(3):271-7 * Single- and double-lumen catheters have a maximum flow rate of 5 mL/sec
Rx only No correlation between in vitro / in vivo testing methods and clinical outcomes have currently been ascertained. Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, ErgoPack, Meet JACC, and Never Settle are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. All other trademarks are trademarks of their respective owners. MC-004521